Afuco™ Anti-Human IFNG ADCC Therapeutic Antibody (NI-0501), ADCC Enhanced
Anti-IFNG ADCC Enhanced Antibody (NI-0501) is an ADCC enhanced antibody produced by our Afuco™ platform. NI-0501 is a fully human monoclonal antibody that neutralizes interferon gamma, a cell-signaling protein believed to play a pivotal role in the development of HLH. In the ongoing Phase II study, NI-0501 was initially administered to patients showing unsatisfactory response or intolerance to conventional therapies including chemotherapy, immune-suppressive medicines, and immune-depleting drugs. The approved amendment to the protocol allows NI-0501 to be administered to patients as a first-line treatment before any other intervention.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-365CL |
| Pricing | Inquiry |
| Host | Human |
| Target | IFNG |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | 4°C or -20°C, avoid repeated freezing and thawing. |